Page last updated: 2024-08-24

cephalosporin c and Borrelia hermsii Infection

cephalosporin c has been researched along with Borrelia hermsii Infection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbour, AG; Dever, LL; Jorgensen, JH; Kazragis, RJ1
Bode, U; Fleischhack, G; Hartmann, C; Hasan, C; Havers, W; Marklein, G; Simon, A; Wulff, B1

Trials

1 trial(s) available for cephalosporin c and Borrelia hermsii Infection

ArticleYear
Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 47, Issue:6

    Topics: Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Escherichia coli; Female; Fever; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Male; Meropenem; Neoplasms; Neutropenia; Prospective Studies; Relapsing Fever; Thienamycins; Time Factors; Treatment Outcome

2001

Other Studies

1 other study(ies) available for cephalosporin c and Borrelia hermsii Infection

ArticleYear
In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Borrelia; Borrelia burgdorferi Group; Brain; Ceftriaxone; Cephalosporins; Injections, Subcutaneous; Lyme Disease; Mice; Mice, Inbred BALB C; Mice, SCID; Microbial Sensitivity Tests; Relapsing Fever; Vancomycin

1996